Morgan Keegan Leaves Skilled Healthcare Group Outperform Rating, $14 PT Unchanged (SKH)

Morgan Keegan left its Skilled Healthcare Group SKH Outperform rating and $14 price target unchanged in a research report published today. In the report, Morgan Keegan states, "We believe that Skilled Healthcare Group can grow earnings by providing high-acuity medically complex services to short-stay patients at its owned and leased nursing homes. We expect the company to augment this internal growth through selective acquisitions. Our Outperform rating reflects our view that the company will benefit from recent changes to the Medicare payment system for nursing homes." Shares of Skilled Healthcare Group were at $11.98 in after hours trading at the time of posting, reflecting no change from Friday's market close.